Browsing Category


General Information, Immunochemistry

RESOLVED: Testing Delay: Chlamydia and Gonococcus PCR (Abbott Multicollect)

As of 11:15 AM, Tuesday, March 24th, the instrument has been repaired. Please direct questions to the “contact us” link above. This post will be retired on Friday, March 27th.

Abbott multi-collect Chlamydia and Gonococcus PCR testing will be delayed until Tuesday, March 24, 2020 due to instrument downtime. Vendor assistance has been requested but is delayed due to the current Covid-19 situation. 

The following tests are affected: Continue Reading

General Information, Immunochemistry

RESOLVED: Testing Delay: Epstein Barr (EBV) IgM

As of 15:00 March 24th, this has been resolved. If you have any questions please use the “contact us” link above.

Testing for EBV IgM is delayed due to the backorder of reagents.  All submitted specimens will be frozen and stored until the reagents are available with an ETA of March 24th. 

If immediate assistance is needed please contact Katie Turner, PhD, or Immunochemistry using the “contact us” link above.

Test Information:
Epstein-Barr VCA (EBV) IgM Acute Antibody  – Epic Code #LAB769, Interface Order Code #10367, CPT: #86665

General Information, Immunochemistry

Immunochemistry Methodology Update

Effective December 11th, 2019, Spectrum Health Regional Laboratory’s Immunochemistry laboratory will be upgrading the following tests from the Immunoassay Vidas platform to the Multiplex flow immunoassay Bioplex 2200 platform.

Cytomegalovirus IgG Antibody

Cytomegalovirus IgM Antibody

Toxoplasma IgG Antibody

Toxoplasma IgM Antibody

Lyme Total Antibody

All tests will continue to have the same collection instructions, processing instructions, rejection criteria, specimen stability, turn-around-time, and qualitative reference ranges of negative. Continue Reading

General Information, Immunochemistry, Main lab, Test Utilization

Protein Electrophoresis Testing Update

In December, serum and urine protein electrophoresis testing will be simplified and standardized.  The only testing available will be:

Protein electrophoresis, serum, IFE if indicated 

Protein electrophoresis, random urine, do IFE if indicated 

Protein electrophoresis, 24 hour urine, do IFE if indicated 

In addition, on December 5, 2019, a new panel will be added which reflects expert recommendations for first line testing for monoclonal gammopathy, including plasma cell myeloma and most cases of amyloidosis, called “Monoclonal Gammopathy Screen

Protein electrophoresis, serum, IFE if indicated 

Kappa and lambda free light chains  Continue Reading

General Information, Immunochemistry

Test Update: Beta-2 Glycoprotein 1 Antibodies

Effective November 5th, testing for Beta-2 Glycoprotein 1 antibodies (IgG and IgM, serum) will change from a reference send out test to Mayo Medical Laboratories to an in-house test available at Spectrum Health Laboratories.  This testing is useful for evaluation of patients of suspected antiphospholipid antibody syndrome.

In addition, a new Antiphospholipid Antibody Syndrome Panel will be added which allows for appropriate and complete testing for antiphospholipid antibody syndrome. This panel includes:

Lupus Screen

Cardiolipin IgG and IgM Antibodies

Beta-2 Glycoprotein 1 IgG and IgM Antibodies

Continue Reading

General Information, Immunochemistry

HSV Testing Update

In an effort to streamline laboratory processes and provide expedited results, the test Herpes Simplex 1 / 2 IGG IGM was replaced with Herpes Simplex Panel on July 17, 2019.  The new panel will still offer both Herpes IgM and Herpes IgG.  The conversion to this panel will allow the lab to report Herpes IgG results faster.  Continue Reading